Abstract
The disappointing results obtained in experimental and clinical efforts to devise effective, specific, active immunotherapy procedures for the treatment of cancer have stimulated renewed interest in mechanisms of non-specific “natural” antitumor surveillance mediated by macrophages and natural killer cells. A significant effort is now underway in many laboratories to develop effective biological response modifier (BRM) agents that can stimulate the antitumor activities of these cells. Liposomes offer a useful carrier system for delivering BRM agents to macrophages in vivo. When injected i.v. the majority of liposomes are taken up by phagocytic reticuloendothelial cells in the liver and spleen, and by circulating monocytes (reviewed in 6). The passive localization of liposomes into mononuclear phagocytes is frustrating to investigators who wish to target liposomes to other cell types in the body, including tumor cells, but provides a highly effective mechanism for “targeting”, albeit passively, of liposome-encapsul-ated materials to macrophages. We have exploited this pathway to deliver natural and synthetic molecules with macrophage activating activity to macrophages in situ.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fidler, I.J. (1980) Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines. Science 208, 1469–1471.
Fidler, I.J., Raz, A., Fogler, W.E., Kirsh, R., Bugelski, P., and Poste, G. (1980), Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. Cancer Research 40, 4460–4466.
Fidler, I.J., Hart, I.R., Raz, A., Fogler, W.E., Kirsh, R. and Poste, G. (1980). Activation of tumoricidal properties in macrophages by liposome-encapsulated lymphokines: in vivo studies. In: Liposomes and Immunobiology, eds., B.H. Tom & H. Six, pp. 109–118. Elsevier/North-Holland, New York.
Fidler, I.J., Sone, S., Fogler, W.E. and Barnes, Z. (1981). Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. PNAS-USA -in press.
Fidler, I.J., Barnes, Z., Fogler, W.E., Kirsh, R., Bugelski, P. and Poste, G. (1982). Evidence for the involvement of macrophages in the eradication of established metastases produced by intravenous injection of liposomes containing macrophage activators. Cancer Research — in press.
Gregoriadis, G. and Allison, A.C. (1980). eds. Liposomes in Biological Systems. Wiley Interscience, New York.
Grisold, D.P., Jr. (1972). Consideration of the subcutaneously implanted B16 melanoma as a screening model for potential anticancer agents. Cancer Chemotherapy Reports, 3, 315–323.
Parant, M. (1979). Biological properties of a new synthetic adjuvant, muramyl dipeptide (MDP). Semin. Immunopathol. 2, 101–118.
Poste, G., Bucana, C., Raz, A., Bugelski, P., Kirsh, R. and Fidler, I.J. (1982). The behavior of intravenously inoculated liposomes in the microcirculation: implications for liposome targeting and drug design. Cancer Research — in press.
Poste, G. and Kirsh, R. (1979). Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages. Cancer Research 39, 2582–2590.
Poste, G., Kirsh, R., Fogler, W.E. and Fidler, I.J. (1979). Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes. Cancer Research 39, 881–892.
Poste, G., Kirsh, R., Raz, A., Sone, S., Bucana, C., Fogler, W.E. and Fidler, I.J. (1980). Activation of tumoricidal properties in macrophages by liposome-encapsulated lymphokines: in vitro studies. In: Liposomes and Immunobiology, eds. B.H. Tom and H. Six, pp. 93–107. Elsevier/North-Holland, New York.
Sone, S. and Fidler, I.J. (1981). In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes. Cell. Immunol. 57, 42–50.
Sone, S., Poste, G. and Fidler, I.J. (1980). Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines. J. Immunol. 124, 2197–2202.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this paper
Cite this paper
Kirsh, R., Poste, G. (1983). Stimulation of Host Resistance to Metastatic Tumors by Macrophage Activating Agents Encapsulated in Liposomes. In: Eisenstein, T.K., Actor, P., Friedman, H. (eds) Host Defenses to Intracellular Pathogens. Advances in Experimental Medicine and Biology, vol 162. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4481-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4481-0_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4483-4
Online ISBN: 978-1-4684-4481-0
eBook Packages: Springer Book Archive